These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36282342)

  • 1. The need to distinguish intervention thresholds and diagnostic thresholds in the management of osteoporosis.
    Kanis JA; McCloskey EV; Harvey NC; Cooper C; Rizzoli R; Dawson-Hughes B; Maggi S; Reginster JY
    Osteoporos Int; 2023 Jan; 34(1):1-9. PubMed ID: 36282342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging.
    Shevroja E; Reginster JY; Lamy O; Al-Daghri N; Chandran M; Demoux-Baiada AL; Kohlmeier L; Lecart MP; Messina D; Camargos BM; Payer J; Tuzun S; Veronese N; Cooper C; McCloskey EV; Harvey NC
    Osteoporos Int; 2023 Sep; 34(9):1501-1529. PubMed ID: 37393412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment of intervention thresholds for very high fracture risk applied to the NOGG guidelines : A report for the National Osteoporosis Guideline Group (NOGG).
    Kanis JA; Johansson H; Harvey NC; Lorentzon M; Liu E; Vandenput L; McCloskey EV
    Osteoporos Int; 2021 Oct; 32(10):1951-1960. PubMed ID: 33813622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FRAX- vs. T-score-based intervention thresholds for osteoporosis.
    Johansson H; Azizieh F; Al Ali N; Alessa T; Harvey NC; McCloskey E; Kanis JA
    Osteoporos Int; 2017 Nov; 28(11):3099-3105. PubMed ID: 28782072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Goal-directed treatment of osteoporosis in Europe.
    Kanis JA; McCloskey E; Branco J; Brandi ML; Dennison E; Devogelaer JP; Ferrari S; Kaufman JM; Papapoulos S; Reginster JY; Rizzoli R
    Osteoporos Int; 2014 Nov; 25(11):2533-43. PubMed ID: 25199574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.
    Kanis JA; Harvey NC; Cooper C; Johansson H; Odén A; McCloskey EV;
    Arch Osteoporos; 2016 Dec; 11(1):25. PubMed ID: 27465509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intervention Thresholds and the Diagnosis of Osteoporosis.
    Kanis JA; McCloskey EV; Harvey NC; Johansson H; Leslie WD
    J Bone Miner Res; 2015 Oct; 30(10):1747-53. PubMed ID: 26390977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intervention thresholds and diagnostic thresholds in the management of osteoporosis.
    Kanis JA; McCloskey EV; Harvey NC; Cooper C; Rizzoli R; Dawson-Hughes B; Maggi S; Reginster JY
    Aging Clin Exp Res; 2022 Dec; 34(12):3155-3157. PubMed ID: 36344804
    [No Abstract]   [Full Text] [Related]  

  • 9. Review of the guideline of the American College of Physicians on the treatment of osteoporosis.
    Kanis JA; Cooper C; Rizzoli R; Reginster JY
    Osteoporos Int; 2018 Jul; 29(7):1505-1510. PubMed ID: 29869039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RECOMMENDATIONS BY GEORGIAN ASSOCIATION OF SKELETAL METABOLIC DISEASES ON THE INITIATION OF TREATMENT WITH USE OF AGE-DEPENDENT INTERVENTION THRESHOLD BASED ON FRAX IN PATIENTS WITH OSTEOPOROSIS.
    Giorgadze E; Tsagareli M; Lomidze M; Sulikashvili T; Jeiranashvili N; Uridia N
    Georgian Med News; 2019 Jun; (291):89-93. PubMed ID: 31418738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FRAX® based intervention thresholds for management of osteoporosis in Singaporean women.
    Chandran M; McCloskey EV; Thu WPP; Logan S; Hao Y; Tay D; Ang WC; Aung TKK; Choo KS; Ali A; Yan SX; Huang XF; Liu XM; Yong EL; Lekamwasam S
    Arch Osteoporos; 2018 Nov; 13(1):130. PubMed ID: 30456726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of strategies for setting intervention thresholds for Chinese postmenopausal women using the FRAX model.
    Liu SY; Huang M; Chen R; Ding N; Liu H; Xie ZJ; Sheng ZF; Luo BH; Ou YN
    Endocrine; 2019 Jul; 65(1):200-206. PubMed ID: 31111436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of calcium supplementation in healthy musculoskeletal ageing : An expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF).
    Harvey NC; Biver E; Kaufman JM; Bauer J; Branco J; Brandi ML; Bruyère O; Coxam V; Cruz-Jentoft A; Czerwinski E; Dimai H; Fardellone P; Landi F; Reginster JY; Dawson-Hughes B; Kanis JA; Rizzoli R; Cooper C
    Osteoporos Int; 2017 Feb; 28(2):447-462. PubMed ID: 27761590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture.
    Ferrari S; Reginster JY; Brandi ML; Kanis JA; Devogelaer JP; Kaufman JM; Féron JM; Kurth A; Rizzoli R
    Arch Osteoporos; 2016 Dec; 11(1):37. PubMed ID: 27800591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment indications and thresholds of intervention: consensus and controversies in osteoporosis.
    Chandran M; Kwee A
    Climacteric; 2022 Feb; 25(1):29-36. PubMed ID: 34313165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Publication outcomes of the abstracts presented at the 2011 European Congress on Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ECCEO-IOF11): A position paper of the European Society for Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ESCEO) and the International Osteoporosis and Other Skeletal Diseases Foundation (IOF).
    Rabenda V; Bruyère O; Cooper C; Rizzoli R; Buckinx F; Quabron A; Reginster JY
    Arch Osteoporos; 2015; 10():11. PubMed ID: 25910868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art-outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
    Diez-Perez A; Brandi ML; Al-Daghri N; Branco JC; Bruyère O; Cavalli L; Cooper C; Cortet B; Dawson-Hughes B; Dimai HP; Gonnelli S; Hadji P; Halbout P; Kaufman JM; Kurth A; Locquet M; Maggi S; Matijevic R; Reginster JY; Rizzoli R; Thierry T
    Aging Clin Exp Res; 2019 Oct; 31(10):1375-1389. PubMed ID: 31422565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA.
    Wright NC; Saag KG; Dawson-Hughes B; Khosla S; Siris ES
    Osteoporos Int; 2017 Apr; 28(4):1225-1232. PubMed ID: 27966104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FRAX calculated without BMD does not correctly identify Caucasian men with densitometric evidence of osteoporosis.
    Hamdy RC; Seier E; Whalen K; Clark WA; Hicks K; Piggee TB
    Osteoporos Int; 2018 Apr; 29(4):947-952. PubMed ID: 29397409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FRAX-based intervention and assessment thresholds for osteoporosis in Iran.
    Khashayar P; Keshtkar A; Ostovar A; Larijani B; Johansson H; Harvey NC; Lorentzon M; McCloskey E; Kanis JA
    Osteoporos Int; 2019 Nov; 30(11):2225-2230. PubMed ID: 31372709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.